Previous 10 | Next 10 |
FREMONT, CA - ( NewMediaWire ) - August 23, 2023 - ABVC BioPharma, Inc . (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced that 60 subjects had been enrolled and 53 had co...
2023-08-22 10:00:48 ET Gainers: Fulcrum Therapeutics ( FULC ) +55% . Renovaro Biosciences ( RENB ) +18% . ProMIS Neurosciences ( PMN ) +17% . cbdMD ( YCBD ) +9% . 60 Degrees Pharmaceuticals ( SXTP ) +7% . Losers: Emergent BioSo...
2023-08-17 13:26:45 ET More on ABVC BioPharma ABVC stock rallies on Chinese licensing deal for psych drugs Thailand FDA approves ABVC BioPharma's phase 2 study plan for its eye-gel substitute ABVC Biopharma stock rises on upcoming US patent for ABV-1504 to treat depres...
FREMONT, CA - ( NewMediaWire ) - August 17, 2023 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in Oncology/Hematology, Neurology, and Ophthalmology, announced today that it had entered into a Cooperation Agr...
2023-08-10 10:23:27 ET Clinical-stage biopharmaceutical firm ABVC BioPharma ( NASDAQ: ABVC ) Thursday said it received a letter from Nasdaq notifying that company had regained compliance with the minimum bid price requirement. The closing bid price of ABVC's common stock was a...
FREMONT, CA - ( NewMediaWire ) - August 10, 2023 - Fremont, CA - ( NewMediaWire ) - August 10, 2023 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, neurology, and oncology/hematology, ...
FREMONT, CA - ( NewMediaWire ) - August 07, 2023 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, neurology, and oncology/hematology, today published a Corporate Update and...
FREMONT, CA - ( NewMediaWire ) - August 3, 2023 - ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company specializing in therapeutic solutions in oncology/hematology, neurology, and ophthalmology, announced that the Science Park Administration in Taiwan approved th...
2023-08-02 08:33:20 ET Adamis Pharmaceuticals Corporation ( ADMP ) -38% . Cambium Networks Corporation CMBM -31% after Q2 earning release . Evolve Transition Infrastructure LP ( OTC:SNMP ) -29% . Latch ( LTCH ) -29% . Driven Brands Holdings ...
2023-08-01 14:10:15 ET ABVC BioPharma ( NASDAQ: ABVC ) stock shot up as much as 100% Tuesday following news that it has entered into a tentative licensing deal to develop its psychiatric drug candidates ABV-1504 and ABV-1505 for the Chinese market. Shares of ABVC were up 42% at ...
News, Short Squeeze, Breakout and More Instantly...
--News Direct-- After successfully completing Phase II clinical trials for their medication to treat Major Depressive Disorder, ABVC BioPharma Inc. and AiBtl BioPharma Inc. are now embarking on a groundbreaking clinical study focused on Depression in Cancer Patients. This new study will i...
FREMONT, CA - ( NewMediaWire ) - July 9, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, neurology, and oncology/hematology, announced today that after successful Phase II c...
FREMONT, CA - ( NewMediaWire ) - July 02, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and oncology/hematology, announced today that the Company and it...